Amgen Names Former BMS Executive as Senior VP of Global Development

From DCAT Value Chain Insights (VCI)

By People On The Move posted 08-19-2014 09:56

Amgen has named  Elliott M. Levy, MD, as senior vice president, global development, effective September 8, 2014. Levy comes to Amgen from Bristol-Myers Squibb (BMS), where he most recently served as senior vice president and head, specialty development.

In his 17-year career at BMS, Levy served in a range of senior positions spanning the spectrum of clinical development and related responsibilities. Prior to his current role, Levy led global pharmacovigilance and epidemiology at BMS. Other previous roles included cardiovascular clinical development, immunoscience clinical research, and global clinical research operations.

Levy is a graduate of Yale College and School of Medicine, where he was chief medical resident and trained in internal medicine and nephrology. He completed fellowship training in clinical research through the Robert Wood Johnson Clinical Scholars program. Before joining BMS, he was a member of the Renal Division at Brigham and Women's Hospital in Boston, where he was an investigator in federally sponsored outcomes research as well as industry-sponsored clinical trials.

Source: Amgen


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription